Radiation Therapy in Treating Patients With Stage II or Stage III Oropharyngeal Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

February 28, 2001

Primary Completion Date

November 30, 2005

Study Completion Date

December 31, 2016

Conditions
Head and Neck CancerRadiation Toxicity
Interventions
DRUG

radioprotection

RADIATION

radiation therapy

Trial Locations (18)

53226

Medical College of Wisconsin Cancer Center, Milwaukee

53405

All Saints Cancer Center at All Saints Healthcare, Racine

54449

CCOP - Marshfield Clinic Research Foundation, Marshfield

64131

CCOP - Kansas City, Kansas City

84143

LDS Hospital, Salt Lake City

84770

Dixie Regional Medical Center, St. George

85013

Foundation for Cancer Research and Education, Phoenix

94115

UCSF Comprehensive Cancer Center, San Francisco

32610-0385

University of Florida Shands Cancer Center, Gainesville

48109-0010

University of Michigan Comprehensive Cancer Center, Ann Arbor

07740-6395

Monmouth Medical Center, Long Branch

08755

Community Regional Cancer Center at Community Medical Center, Toms River

19107-5541

Kimmel Cancer Center at Thomas Jefferson University - Philadelphia, Philadelphia

77030-4009

M.D. Anderson Cancer Center at University of Texas, Houston

05701

Community Cancer Center at Rutland Regional Medical Center, Rutland

T6G 2R7

Stollery Children's Hospital at University of Alberta Hospital, Edmonton

H2L 4MI

Centre Hospitalier de l'Universite de Montreal, Montreal

H2W 1S6

McGill Cancer Centre at McGill University, Montreal

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Radiation Therapy Oncology Group

NETWORK

NCT00006360 - Radiation Therapy in Treating Patients With Stage II or Stage III Oropharyngeal Cancer | Biotech Hunter | Biotech Hunter